|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 13
Zeitschriftenartikel
Hehlmann, Rüdiger; Voskanyan, Astghik; Lauseker, Michael; Pfirrmann, Markus; Hasford, Jörg und Kolb, Hans-Jochem
(2020):
High-risk additional chromosomal abnormalities at low blast counts herald death by CML.
In: Leukemia, Bd. 34: S. 2074-2086
[PDF, 1MB]
Steger, Brigitte; Floro, Lajos; Amberger, Daniel C.; Kroell, Tanja; Tischer, Johanna; Kolb, Hans-Jochem und Schmetzer, Helga Maria
(2020):
WT1, PRAME, and PR3 mRNA Expression in Acute Myeloid Leukemia (AML).
In: Journal of Immunotherapy, Bd. 43, Nr. 6: S. 204-215
Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W.; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Alice and Haferlach und Pfirrmann, Markus
(2019):
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
In: Haematologica, Bd. 104, Nr. 5: S. 955-962
Lopez, Annika Hirn; Deen, Diana; Fischer, Zuzanna; Rabe, Alexander; Ansprenger, Christian; Stein, Kathy; Vogt, Valentin; Schick, Julia; Kroell, Tanja; Krämer, Doris; Kolb, Hans-Jochem; Tischer, Johanna; Schmid, Christoph und Schmetzer, Helga
(2019):
Role of Interferon (IFN)alpha in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
In: Journal of Immunotherapy, Bd. 42, Nr. 5: S. 143-161
Engel, Nicole; Rovo, Alicia; Badoglio, Manuela; Labopin, Myriam; Basak, Grzegorz W.; Beguin, Yves; Guyotat, Denis; Ljungman, Per; Nagler, Arnon; Schattenberg, Anton; Schröder, Thomas; Schroyens, Wilfried; Tischer, Johanna; Socie, Gerard; Kolb, Hans-Jochem; Tichelli, Andre; Salooja, Nina und Duarte, Rafael F.
(2019):
European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation.
In: Leukemia, Bd. 33, Nr. 2: S. 508-517
Norden, Jean; Pearce, Kim F.; Irving, Julie A. E.; Collin, Matthew P.; Wang, Xiao N.; Wolff, Daniel; Kolb, Hans-Jochem; Socie, Gerard; Kuzmina, Zoya; Greinix, Hildegard; Holler, Ernst; Rocha, Vanderson; Gluckman, Eliane; Hromadnikova, Ilona und Dickinson, Anne M.
(2018):
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation.
In: International Journal of Immunogenetics, Bd. 45, Nr. 5: S. 247-256
Ansprenger, Christian; Vogt, Valentin; Schick, Julia; Hirn-Lopez, Annika; Vokac, Yvonne; Harabacz, Ihor; Braeu, Marion; Kröll, Tanja; Karenberg, Axel; Kolb, Hans-Jochem und Schmetzer, Helga
(2018):
Paramunity-inducing Factors (PINDs) in dendritic cell (DC) cultures lead to impaired antileukemic functionality of DC-stimulated T-cells.
In: Cellular Immunology, Bd. 328: S. 33-48
Hehlmann, Rüdiger; Lauseker, Michael; Saußele, Susanne; Hochhaus, Andreas; Hasford, Joerg; Pfirrmann, Markus; Kolb, Hans-Jochem; Spiekermann, Karsten; Fabarius, Alice; Müller, M. C.; Proetel, Ulrike; Kohlbrenner, K.; Voskanyan, A.; Rinaldetti, S.; Seifarth, W.; Spieß, B.; Krause, S. W.; Neubauer, A.; Burchert, A.; Hossfeld, Dieter K.; Schafhausen, P.; Nerl, C.; Gratwohl, A.; Heim, D.; Baerlocher, Gabriela M.; Brümmendorf, Tim H.; Fuchs, R.; Haferlach, C.; Jeromin, S.; Schlegelberger, Brigitte; Balleisen, L.; Goebeler, M. C.; Hänel, M.; Ho, A.; Dengler, J.; Falge, C.; Kanz, L.; Kremers, S.; Kneba, M.; Stegelmann, F.; Köhne, C. A.; Lindemann, H. W.; Waller, C. F.; Pfreundschuh, Michael; Berdel, Wolfgang E.; Müller, L.; Edinger, M.; Mayer, J.; Beelen, D. W.; Bentz, M.; Link, H.; Hertenstein, Bernd; Wernli, Martin; Schlegel, F.; Schlag, R.; Wit, M. de; Trumper, L.; Hebart, H.; Hahn, M.; Thomalla, J.; Scheid, C.; Verbeek, W.; Eckart, M. J.; Gassmann, W.; Pezzutto, A.; Schenk, M.; Brossart, P.; Geer, T.; Bildat, S. und Schäfer, E.
(2017):
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
In: Leukemia, Bd. 31, Nr. 11: S. 2398-2406
Brissot, Eolia; Labopin, Myriam; Stelljes, Matthias; Ehninger, Gerhard; Schwerdtfeger, Rainer; Finke, Jürgen; Kolb, Hans-Jochem; Ganser, Arnold; Schäfer-Eckart, Kerstin; Zander, Axel R.; Bunjes, Donald; Mielke, Stephan; Bethge, Wolfgang A.; Milpied, Noel; Kalhs, Peter; Blau, Igor-Woflgang; Kröger, Nicolaus; Vitek, Antonin; Gramatzki, Martin; Holler, Ernst; Schmid, Christoph; Esteve, Jordi; Mohty, Mohamad und Nagler, Arnon
(2017):
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
In: Journal of Hematology & Oncology
10:130
[PDF, 557kB]
Thiel, Uwe; Wawer, Angela; Luettichau, Irene von; Bender, Hans-Ulrich; Blaeschke, Franziska; Grunewald, Thomas G. P.; Steinborn, Marc; Röper, Barbara; Bonig, Halvard; Klingebiel, Thomas; Bader, Peter; Koscielniak, Ewa; Paulussen, Michael; Dirksen, Uta; Juergens, Heribert; Kolb, Hans-Jochem und Burdach, Stefan E. G.
(2016):
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
In: Oncotarget, Bd. 7, Nr. 43: S. 70959-70968
Buhmann, Raymund; Michael, Stanglmaier; Juergen, Hess; Horst, Lindhofer; Peschel, Christian und Kolb, Hans-Jochem
(2013):
Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial.
In: Journal of Translational Medicine
11:160
[PDF, 484kB]
Kolb, Hans-Jochem; Schmid, Christoph; Chen, Xiao; Woiciechowski, Anja; Roskrow, Marie; Weber, Martin; Guenther, Wolfgang; Ledderose, Georg und Schleuning, Michael
(2003):
Adoptive Immunotherapy in Chimeras with Donor Lymphocytes.
In: Acta Haematologica, Nr. 2-3: S. 110-120
[PDF, 165kB]
Hehlmann, Rüdiger; Hochhaus, Andreas; Kolb, Hans-Jochem; Hasford, Joerg; Gratwohl, Alois; Heimpel, Hermann; Siegert, Wolfgang; Finke, Jürgen; Ehninger, Gerhard; Holler, Ernst; Berger, Ute; Pfirrmann, Markus; Muth, Alexander; Zander, Alex; Fauser, Axel A.; Heyll, Axel; Nerl, Christoph; Hossfeld, Dieter K.; Löffler, Helmut; Pralle, Hans; Queißer, Wolfgang und Tobler, Andreas
(1. Dezember 1999):
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
In: Blood, Bd. 94, Nr. 11, 10572078: S. 3668-3677